| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |